DNA damage-induced activation of ATM and ATM-dependent signaling pathways

DNA Repair

Volumn 3, Issue 8-9, 2004, Pages 889-900

  Kurz, Ebba U ^a   Lees Miller, Susan P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

A T; ataxia telangiectasia; ataxia telangiectasia mutated; ATM; ATM and Rad3 related; ATR; DNA double strand break; DNA dependent protein kinase catalytic subunit; DNA PKcs; double stranded; ds; DSB; HEAT

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; APIGENIN; ATM PROTEIN; BIOCHANIN A; BIOFLAVONOID; BUTYRIC ACID; CAMPTOTHECIN; CARMUSTINE; CHLOROQUINE; CISPLATIN; CROSS LINKING REAGENT; CYTARABINE; DAIDZEIN; DOUBLE STRANDED DNA; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GENISTEIN; HYDROXYUREA; KAEMPFEROL; LUTEOLIN; MELPHALAN; MESYLIC ACID METHYL ESTER; METHOTREXATE; METHYLNITRONITROSOGUANIDINE; MITOMYCIN C; PROTEIN P53; QUERCETIN; UNINDEXED DRUG;

ATAXIA TELANGIECTASIA; CELL CYCLE; DNA DAMAGE; DNA STRAND BREAKAGE; DOWN REGULATION; GENOTOXICITY; HUMAN; IONIZING RADIATION; MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RADIATION INJURY; RADIATION RESPONSE; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; ULTRAVIOLET A RADIATION; ULTRAVIOLET C RADIATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 2642528031     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.03.029     Document Type: Review

References (112)

1. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3:2003;155-168
2. Shiloh Y. ATM: ready, set, go. Cell Cycle. 2:2003;116-117
3. Lavin M.F., Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15:1997;177-202
4. Savitsky K., Sfez S., Tagle D.A., Ziv Y., Sartiel A., Collins F.S., Shiloh Y., Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4:1995;2025-2032
5. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753
6. Khanna K., Lavin M., Jackson S., Mulhern T. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 8:2001;1052-1065
7. Goodarzi A.A., Block W.D., Lees-Miller S.P. The role of ATM and ATR in DNA damage-induced cell cycle control. Prog. Cell Cycle Res. 5:2003;393-411
8. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science. 298:2002;1912-1934
9. Kim S.T., Lim D.S., Canman C.E., Kastan M.B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274:1999;37538-37543
10. O'Neill T., Dwyer A.J., Ziv Y., Chan D.W., Lees-Miller S.P., Abraham R.H., Lai J.H., Hill D., Shiloh Y., Cantley L.C., Rathbun G.A. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J. Biol. Chem. 275:2000;22719-22727
11. Bosotti R., Isacchi A., Sonnhammer E.L. FAT: a novel domain in PIK-related kinases. Trends Biochem. Sci. 25:2000;225-227
12. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:2003;499-506
13. Perry J., Kleckner N. The ATRs, ATMs, and TORs are giant HEAT repeat proteins. Cell. 112:2003;151-155
14. Llorca O., Rivera-Calzada A., Grantham J., Willison K.R. Electron microscopy and 3D reconstructions reveal that human ATM kinase uses an arm-like domain to clamp around double-stranded DNA. Oncogene. 22:2003;3867-3874
15. Leuther K.K., Hammarsten O., Kornberg R.D., Chu G. Structure of DNA-dependent protein kinase: implications for its regulation by DNA. EMBO J. 18:1999;1114-1123
16. Cary R.B., Peterson S.R., Wang J., Bear D.G., Bradbury E.M., Chen D.J. DNA looping by Ku and the DNA-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4267-4272
17. Smith G.C., Cary R.B., Lakin N.D., Hann B.C., Teo S.H., Chen D.J., Jackson S.P. Purification and DNA binding properties of the ataxia- telangiectasia gene product ATM. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11134-11139
18. Merkle D., Douglas P., Moorhead G.B., Leonenko Z., Yu Y., Cramb D., Bazett-Jones D.P., Lees-Miller S.P. The DNA-dependent protein kinase interacts with DNA to form a protein-DNA complex that is disrupted by phosphorylation. Biochemistry. 41:2002;12706-12714
19. Yaneva M., Kowalewski T., Lieber M.R. Interaction of DNA-dependent protein kinase with DNA and with Ku: biochemical and atomic-force microscopy studies. EMBO J. 16:1997;5098-5112
20. Banin S., Moyal L., Shieh S., Taya Y., Anderson C.W., Chessa L., Smorodinsky N.I., Prives C., Reiss Y., Shiloh Y., Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281:1998;1674-1677
21. Lakin N.D., Weber P., Stankovic T., Rottinghaus S.T., Taylor A.M., Jackson S.P. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene. 13:1996;2707-2716
22. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679
23. Chan D.W., Gately D.P., Urban S., Galloway A.M., Lees-Miller S.P., Yen T., Allalunis-Turner J. Lack of correlation between ATM protein expression and tumour cell radiosensitivity. Int. J. Radiat. Biol. 74:1998;217-224
24. Kozlov S., Gueven N., Keating K., Ramsay J., Lavin M.F. ATP activates ATM in vitro: importance of autophosphorylation. J. Biol. Chem. 278:2003;9309-9317
25. Chan D.W., Son S.C., Block W., Ye R., Khanna K.K., Wold M.S., Douglas P., Goodarzi A.A., Pelley J., Taya Y., Lavin M.F., Lees-Miller S.P. Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase. J. Biol. Chem. 275:2000;7803-7810
26. Suzuki K., Kodama S., Watanabe M. Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J. Biol. Chem. 274:1999;25571-25575
27. Andegeko Y., Moyal L., Mittelman L., Tsarfaty I., Shiloh Y., Rotman G. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 276:2001;38224-38230
28. Petrini J.H., Stracker T.H. The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol. 13:2003;458-462
29. van den Bosch M., Bree R.T., Lowndes N.F. The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep. 4:2003;844-849
30. Stewart G.S., Maser R.S., Stankovic T., Bressan D.A., Kaplan M.I., Jaspers N.G., Raams A., Byrd P.J., Petrini J.H., Taylor A.M. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 99:1999;577-587
31. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22:2003;5612-5621
32. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., Weitzman M.D. The Mre11 complex is required for ATM activation and the G(2)/M checkpoint. EMBO J. 22:2003;6610-6620
33. Lukas C., Falck J., Bartkova J., Bartek J., Lukas J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol. 5:2003;255-260
34. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146:1999;905-916
35. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., Jackson S.P. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 421:2003;952-956
36. Mochan T.A., Venere M., DiTullio R.A. Jr., Halazonetis T.D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res. 63:2003;8586-8591
37. Foray N., Marot D., Gabriel A., Randrianarison V., Carr A.M., Perricaudet M., Ashworth A., Jeggo P. A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. EMBO J. 22:2003;2860-2871
38. Kim S.T., Xu B., Kastan M.B. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev. 16:2002;560-570
39. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30:2002;285-289
40. Gatei M., Zhou B.B., Hobson K., Scott S., Young D., Khanna K.K. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J. Biol. Chem. 276:2001;17276-17280
41. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:2000;927-939
42. Yu X., Chini C.C., He M., Mer G., Chen J. The BRCT domain is a phospho-protein binding domain. Science. 302:2003;639-642
43. Manke I.A., Lowery D.M., Nguyen A., Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science. 302:2003;636-639
44. Rodriguez M., Yu X., Chen J., Songyang Z. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278:2003;52914-52918
45. Liu Y., Virshup D.M., White R.L., Hsu L.C. Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha. Cancer Res. 62:2002;6357-6361
46. Li N., Banin S., Ouyang H., Li G.C., Courtois G., Shiloh Y., Karin M., Rotman G. ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J. Biol. Chem. 276:2001;8898-8903
47. Sapkota G.P., Deak M., Kieloch A., Morrice N., Goodarzi A.A., Smythe C., Shiloh Y., Lees-Miller S.P., Alessi D.R. Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366. Biochem. J. 368:2002;507-516
48. Baskaran R., Wood L.D., Whitaker L.L., Canman C.E., Morgan S.E., Xu Y., Barlow C., Baltimore D., Wynshaw-Boris A., Kastan M.B., Wang J.Y. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 387:1997;516-519
49. Gatei M., Sloper K., Sorensen C., Syljuasen R., Falck J., Hobson K., Savage K., Lukas J., Zhou B.B., Bartek J., Khanna K.K. Ataxia-telangiectasia- mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J. Biol. Chem. 278:2003;14806-14811
50. Zhang J., Willers H., Feng Z., Ghosh J.C., Kim S., Weaver D.T., Chung J.H., Powell S.N., Xia F. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol. Cell Biol. 24:2004;708-718
51. Lee J.S., Collins K.M., Brown A.L., Lee C.H., Chung J.H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature. 404:2000;201-204
52. Shafman T., Khanna K.K., Kedar P., Spring K., Kozlov S., Yen T., Hobson K., Gatei M., Zhang N., Watters D., Egerton M., Shiloh Y., Kharbanda S., Kufe D., Lavin M.F. Interaction between ATM protein and c-Abl in response to DNA damage. Nature. 387:1997;520-523
53. Chen G., Yuan S.S., Liu W., Xu Y., Trujillo K., Song B., Cong F., Goff S.P., Wu Y., Arlinghaus R., Baltimore D., Gasser P.J., Park M.S., Sung P., Lee E.Y. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 274:1999;12748-12752
54. Foray N., Marot D., Randrianarison V., Venezia N.D., Picard D., Perricaudet M., Favaudon V., Jeggo P. Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. Mol. Cell Biol. 22:2002;4020-4032
55. Powell S.N., Kachnic L.A. Roles of BRCA1 and BRCA2 in homologous recombination. Oncogene. 22:2003;5784-5791
56. Habraken Y., Jolois O., Piette J. Differential involvement of the hMRE11/hRAD50/NBS1 complex, BRCA1 and MLH1 in NF-kappaB activation by camptothecin and X-ray. Oncogene. 22:2003;6090-6099
57. Amundson S.A., Bittner M., Fornace A.J. Jr. Functional genomics as a window on radiation stress signaling. Oncogene. 22:2003;5828-5833
58. Heinloth A.N., Shackelford R.E., Innes C.L., Bennett L., Li L., Amin R.P., Sieber S.O., Flores K.G., Bushel P.R., Paules R.S. ATM-dependent and -independent gene expression changes in response to oxidative stress, gamma irradiation, and UV irradiation. Radiat. Res. 160:2003;273-290
59. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science. 302:2003;1036-1038
60. Siliciano J.D., Canman C.E., Taya Y., Sakaguchi K., Appella E., Kastan M.B. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11:1997;3471-3481
61. Saito S., Goodarzi A.A., Higashimoto Y., Noda Y., Lees-Miller S.P., Appella E., Anderson C.W. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem. 277:2002;12491-12494
62. Povirk L.F. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin. Mutat. Res. 355:1996;71-89
63. Perkins E.J., Nair A., Cowley D.O., Van Dyke T., Chang Y., Ramsden D.A. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev. 16:2002;159-164
64. Ye R., Bodero A., Zhou B.B., Khanna K.K., Lavin M.F., Lees-Miller S.P. The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner. J. Biol. Chem. 276:2001;4828-4833
65. Ye R., Goodarzi A.A., Kurz E.U., Saito S., Higashimoto Y., Lavin M.F., Appella E., Anderson C.W., Lees-Miller S.P. The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM. DNA Repair (Amst.). 3:2004;235-244
66. Snyder R.D., Gillies P.J. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II - interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ. Mol. Mutagen. 40:2002;266-276
67. O'Prey J., Brown J., Fleming J., Harrison P.R. Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochem. Pharmacol. 66:2003;2075-2088
68. Miyakoda M., Suzuki K., Kodama S., Watanabe M. Activation of ATM and phosphorylation of p53 by heat shock. Oncogene. 21:2002;1090-1096
69. Suzuki A., Kusakai G., Kishimoto A., Lu J., Ogura T., Lavin M.F., Esumi H. Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J. Biol. Chem. 278:2003;48-53
70. Yang D.Q., Kastan M.B. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat. Cell Biol. 2:2000;893-898
71. Barzilai A., Rotman G., Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst.). 1:2002;3-25
72. Pilch D.R., Sedelnikova O.A., Redon C., Celeste A., Nussenzweig A., Bonner W.M. Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem. Cell Biol. 81:2003;123-129
73. Konishi A., Shimizu S., Hirota J., Takao T., Fan Y., Matsuoka Y., Zhang L., Yoneda Y., Fujii Y., Skoultchi A.I., Tsujimoto Y. Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks. Cell. 114:2003;673-688
74. Gillespie D.A., Vousden K.H. The secret life of histones. Cell. 114:2003;655-656
75. Lees-Miller S.P., Meek K. Repair of DNA double strand breaks by nonhomologous end joining. Biochimie. 85:2003;1161-1173
76. Fei P., El-Deiry W.S. P53 and radiation responses. Oncogene. 22:2003;5774-5783
77. Zhang Y., Ma W.Y., Kaji A., Bode A.M., Dong Z. Requirement of ATM in UVA-induced signaling and apoptosis. J. Biol. Chem. 277:2002;3124-3131
78. Turenne G.A., Paul P., Laflair L., Price B.D. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. Oncogene. 20:2001;5100-5110
79. Fritsche M., Haessler C., Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene. 8:1993;307-318
80. Tang D., Wu D., Hirao A., Lahti J.M., Liu L., Mazza B., Kidd V.J., Mak T.W., Ingram A.J. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277:2002;12710-12717
81. Ashcroft M., Taya Y., Vousden K.H. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell Biol. 20:2000;3224-3233
82. Kobayashi T., Ruan S., Jabbur J.R., Consoli U., Clodi K., Shiku H., Owen-Schaub L.B., Andreeff M., Reed J.C., Zhang W. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment. Cell Death Differ. 5:1998;584-591
83. Gottifredi V., Shieh S., Taya Y., Prives C. p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc. Natl. Acad. Sci. U.S.A. 98:2001;1036-1041
84. Adamson A.W., Kim W.J., Shangary S., Baskaran R., Brown K.D. ATM is activated in response to N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA alkylation. J. Biol. Chem. 277:2002;38222-38229
85. Inoue T., Geyer R.K., Yu Z.K., Maki C.G. Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents. FEBS Lett. 490:2001;196-201
86. Jaiswal A.S., Narayan S. S(N)2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression. Mutat. Res. 500:2002;17-30
87. Damia G., Filiberti L., Vikhanskaya F., Carrassa L., Taya Y., D'Incalci M., Broggini M. Cisplatinum and taxol induce different patterns of p53 phosphorylation. Neoplasia. 3:2001;10-16
88. Wang J., Friedman E. Downregulation of p53 by sustained JNK activation during apoptosis. Mol. Carcinog. 29:2000;179-188
89. Hammond E.M., Dorie M.J., Giaccia A.J. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to re-oxygenation. J. Biol. Chem. 278:2003;12207-12213
90. Shackelford R.E., Innes C.L., Sieber S.O., Heinloth A.N., Leadon S.A., Paules R.S. The Ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts. J. Biol. Chem. 276:2001;21951-21959
91. Chen K., Albano A., Ho A., Keaney J.F. Jr. Activation of p53 by oxidative stress involves PDGFbeta receptor-mediated ATM kinase activation. J. Biol. Chem. 278:2003;39527-39533
92. Hofseth L.J., Saito S., Hussain S.P., Espey M.G., Miranda K.M., Araki Y., Jhappan C., Higashimoto Y., He P., Linke S.P., Quezado M.M., Zurer I., Rotter V., Wink D.A., Appella E., Harris C.C. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl. Acad. Sci. U.S.A. 100:2003;143-148
93. Long X., Wu G., Gaa S.T., Rogers T.B. Inhibition of protein phosphatase-1 is linked to phosphorylation of p53 and apoptosis. Apoptosis. 7:2002;31-39
94. Yih L.H., Lee T.C. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res. 60:2000;6346-6352
95. Mei N., Lee J., Sun X., Xing J.Z., Hanson J., Le C., Weinfeld M. Genetic predisposition to the cytotoxicity of arsenic: the role of DNA damage and ATM. FASEB J. 17:2003;2310-2312
96. Ha L., Ceryak S., Patierno S.R. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278:2003;17885-17894
97. Nur-E-Kamal A., Li T.K., Zhang A., Qi H., Hars E.S., Liu L.F. Single-stranded DNA induces ataxia telangiectasia mutant (ATM)/p53-dependent DNA damage and apoptotic signals. J. Biol. Chem. 278:2003;12475-12481
98. Mirzayans R., Pollock S., Scott A., Gao C.Q., Murray D. Metabolic labeling of human cells with tritiated nucleosides results in activation of the ATM-dependent p53 signaling pathway and acceleration of DNA repair. Oncogene. 22:2003;5562-5571
99. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402
100. Smith G.C., di Fagagna F., Lakin N.D., Jackson S.P. Cleavage and inactivation of ATM during apoptosis. Mol. Cell Biol. 19:1999;6076-6084
101. Chen S., Paul P., Price B.D. ATM's leucine-rich domain and adjacent sequences are essential for ATM to regulate the DNA damage response. Oncogene. 22:2003;6332-6339
102. Yamane K., Wu X., Chen J. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. Mol. Cell Biol. 22:2002;555-566
103. Block W.D., Yu Y., Lees-Miller S.P. Phosphatidyl inositol 3-kinase like serine/threonine protein kinases (PIKKs) are required for DNA damage-induced phosphorylation of the 32-kDa subunit of replication protein A at threonine 21. Nucleic Acids Res. 32:2004;997-1005
104. Kim G.D., Choi Y.H., Dimtchev A., Jeong S.J., Dritschilo A., Jung M. Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase. J. Biol. Chem. 274:1999;31127-31130
105. Yuan S.S., Chang H.L., Hou M.F., Chan T.F., Kao Y.H., Wu Y.C., Su J.H. Neocarzinostatin induces Mre11 phosphorylation and focus formation through an ATM- and NBS1-dependent mechanism. Toxicology. 177:2002;123-130
106. Fan W., Jin S., Tong T., Zhao H., Fan F., Antinore M.J., Rajasekaran B., Wu M., Zhan Q. BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. J. Biol. Chem. 277:2002;8061-8067
107. Jallepalli P.V., Lengauer C., Vogelstein B., Bunz F. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278:2003;20475-20479
108. Ahn J., Urist M., Prives C. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. J. Biol. Chem. 278:2003;20480-20489
109. Takai H., Naka K., Okada Y., Watanabe M., Harada N., Saito S., Anderson C.W., Appella E., Nakanishi M., Suzuki H., Nagashima K., Sawa H., Ikeda K., Motoyama N. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J. 21:2002;5195-5205
110. Krause D.R., Jonnalagadda J.C., Gatei M.H., Sillje H.H., Zhou B.B., Nigg E.A., Khanna K. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Oncogene. 22:2003;5927-5937
111. Groth A., Lukas J., Nigg E.A., Sillje H.H., Wernstedt C., Bartek J., Hansen K. Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint. EMBO J. 22:2003;1676-1687
112. Yuan S.S., Chang H.L., Lee E.Y. Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM(-/-) and c-Abl(-/-) cells. Mutat. Res. 525:2003;85-92